526-302 Biotechnology 2: Processes & Innovations

Microbiology 526-201; biochemistry 521-211 and 521-212; at least one of microbiology 526-221, biochemistry 521-220, genetics 652-216. Microbiology 526-301 is desirable but not essential.

BBiomedSc students: microbiology 526-201 or 526-205; 521-213 and 536-250.

By the end of the subject students should be able to:

• comprehend many of the issues, concepts and difficulties involved in developing new biotechnology products (for instance hormones, cytokines, vaccines, DNA probes, and biosensors), and in developing biotechnology-based manufacturing processes;

• describe the principles underlying microbial processes currently in operation in industry and environmental management, such as for example those used in manufacture of amino acids, enzymes, sugars, antibiotics and related biochemical products;

• recognise the difficulties involved in transition between laboratory and larger modes of operation;

• appreciate the importance of rational, independent and critical thought in biotechnology, such as is needed when assessing the consequences of deliberate releases of genetically modified organisms into the environment; and

• recognise the past contributions of biotechnology to society (for example in the food, health care and waste-management industries, and its potential for further improvement of human welfare) as illustrated by the ongoing contribution of molecular biology to advances in medicine.

A 2-hour end-of-semester written examination (80%) and written assignments not exceeding a total of 3000 words (20%).